First successful CAR-T treatment for muscle inflammation
Researchers in Germany have helped a patient to overcome anti-synthetase syndrome muscle inflammation using CAR-T cells.
Stay updated with breaking news from Georg Schett. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Researchers in Germany have helped a patient to overcome anti-synthetase syndrome muscle inflammation using CAR-T cells.
– Company has obtained exclusive worldwide license for a fully human CD19 binder with clinical tolerability data that support potential clinical development in autoimmune diseases – ... | October 11, 2022
German researchers successfully cure multiple patients suffering from severe autoimmune disease using CAR T cells.
Five seriously ill lupus patients have seen their disease driven into remission after a single infusion of modified immune cells, in a small trial that borrows from cancer therapy to harness patients' own cells to treat the autoimmune condition.
CAR-T immune therapies were developed to fight cancer. The same technique just showed promise treating lupus, but it costs hundreds of thousands.